NCT05323721View on ClinicalTrials.gov

Effectiveness and Chemoprevention Efficacy of Implementing Seasonal Malaria Chemoprevention in Karamoja Region, Uganda

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

6,805

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

November 1, 2022

Study Completion Date

December 1, 2023

Conditions
Malaria
Interventions
DRUG

Sulfadoxine pyrimethamine and amodiaquine

This is where children 3-59 months will receive SPAQ for SMC

DRUG

dihydroartemisinin-piperaquine

This is where children 3-59 months will receive DP for SMC

Trial Locations (1)

Unknown

Amudat, Amudat

All Listed Sponsors
lead

Malaria Consortium

OTHER